20分
2022 Interview with Dr Matthew O'Connor LongeCity interviews
-
- 科学
Founder of Underdog Pharmaceutical, now renamed Cyclarity Therapeutics, Dr Matthew O'Connor talks about new cyclodextrin-based drugs in development.
Founder of Underdog Pharmaceutical, now renamed Cyclarity Therapeutics, Dr Matthew O'Connor talks about new cyclodextrin-based drugs in development.
20分